Walmart Settles with DOJ Over Opioid Prescription Allegations for $50 Million
Walmart has agreed to pay $50 million to settle allegations from the U.S. Department of Justice (DOJ) that its pharmacies filled thousands of invalid opioid and controlled-substance prescriptions between June 2013 and December 2020. The DOJ claimed Walmart's compliance team ignored warning signs such as dangerous drug combinations, repeated high-dose prescriptions, and early refill requests from prescribers suspected to be operating
Tickers: $WMT
Topics: DOJ settlement opioids pharmacies